| pubmed-article:10456462 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10456462 | lifeskim:mentions | umls-concept:C0439849 | lld:lifeskim |
| pubmed-article:10456462 | lifeskim:mentions | umls-concept:C0032143 | lld:lifeskim |
| pubmed-article:10456462 | lifeskim:mentions | umls-concept:C0205042 | lld:lifeskim |
| pubmed-article:10456462 | lifeskim:mentions | umls-concept:C0021308 | lld:lifeskim |
| pubmed-article:10456462 | lifeskim:mentions | umls-concept:C0030190 | lld:lifeskim |
| pubmed-article:10456462 | lifeskim:mentions | umls-concept:C0038418 | lld:lifeskim |
| pubmed-article:10456462 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:10456462 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:10456462 | lifeskim:mentions | umls-concept:C0040044 | lld:lifeskim |
| pubmed-article:10456462 | lifeskim:mentions | umls-concept:C0445223 | lld:lifeskim |
| pubmed-article:10456462 | lifeskim:mentions | umls-concept:C0175566 | lld:lifeskim |
| pubmed-article:10456462 | lifeskim:mentions | umls-concept:C1552599 | lld:lifeskim |
| pubmed-article:10456462 | lifeskim:mentions | umls-concept:C1704787 | lld:lifeskim |
| pubmed-article:10456462 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:10456462 | pubmed:dateCreated | 1999-10-18 | lld:pubmed |
| pubmed-article:10456462 | pubmed:abstractText | Type 1 plasminogen activator inhibitor (PAI-1) is considered to be risk factor for acute myocardial infarction (AMI). A rebound of circulating PAI-1 has been reported after rt-PA administration. We investigated the relationships between PAI-1 levels before and after thrombolytic therapy with streptokinase (SK) as compared to rt-PA and the patency of infarct-related arteries. | lld:pubmed |
| pubmed-article:10456462 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10456462 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10456462 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10456462 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10456462 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10456462 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10456462 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10456462 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10456462 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10456462 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10456462 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:10456462 | pubmed:issn | 0340-6245 | lld:pubmed |
| pubmed-article:10456462 | pubmed:author | pubmed-author:LévySS | lld:pubmed |
| pubmed-article:10456462 | pubmed:author | pubmed-author:PaganelliFF | lld:pubmed |
| pubmed-article:10456462 | pubmed:author | pubmed-author:AlessiM CMC | lld:pubmed |
| pubmed-article:10456462 | pubmed:author | pubmed-author:MaixentJ MJM | lld:pubmed |
| pubmed-article:10456462 | pubmed:author | pubmed-author:MorangePP | lld:pubmed |
| pubmed-article:10456462 | pubmed:author | pubmed-author:VagueI JIJ | lld:pubmed |
| pubmed-article:10456462 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10456462 | pubmed:volume | 82 | lld:pubmed |
| pubmed-article:10456462 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10456462 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10456462 | pubmed:pagination | 104-8 | lld:pubmed |
| pubmed-article:10456462 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:10456462 | pubmed:meshHeading | pubmed-meshheading:10456462... | lld:pubmed |
| pubmed-article:10456462 | pubmed:meshHeading | pubmed-meshheading:10456462... | lld:pubmed |
| pubmed-article:10456462 | pubmed:meshHeading | pubmed-meshheading:10456462... | lld:pubmed |
| pubmed-article:10456462 | pubmed:meshHeading | pubmed-meshheading:10456462... | lld:pubmed |
| pubmed-article:10456462 | pubmed:meshHeading | pubmed-meshheading:10456462... | lld:pubmed |
| pubmed-article:10456462 | pubmed:meshHeading | pubmed-meshheading:10456462... | lld:pubmed |
| pubmed-article:10456462 | pubmed:meshHeading | pubmed-meshheading:10456462... | lld:pubmed |
| pubmed-article:10456462 | pubmed:meshHeading | pubmed-meshheading:10456462... | lld:pubmed |
| pubmed-article:10456462 | pubmed:meshHeading | pubmed-meshheading:10456462... | lld:pubmed |
| pubmed-article:10456462 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10456462 | pubmed:articleTitle | Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery. | lld:pubmed |
| pubmed-article:10456462 | pubmed:affiliation | Division of Cardiology, University of Marseille, School of Medicine, France. | lld:pubmed |
| pubmed-article:10456462 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10456462 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10456462 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:10456462 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:10456462 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10456462 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10456462 | lld:pubmed |
